R. Gonzalezamaro et al., ROLE OF IL-10 IN THE ABNORMALITIES OF EARLY CELL ACTIVATION EVENTS OFLYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Journal of autoimmunity (Print), 11(5), 1998, pp. 395-402
Lymphocytes from patients with systemic lupus erythematosus (SLE) exhi
bit abnormalities in early cell activation events as well as increased
production of IL-10. We explored the possible role of IL-10 on defect
ive cell activation events of SLE lymphocytes and first studied the in
vitro effect of IL-10 on peripheral blood mononuclear cells(PBMNC) fr
om healthy subjects. After 5 days of culture in the presence of exogen
ous IL-10, these cells demonstrated abnormal expression of CD69 as wel
l as high intracellular pH and defective activation of the Na+/H+ anti
-porter by PMA. We then investigated the effect of IL-10 blockade on P
BMNC from SLE patients. SLE PBMNC cultured for 5 days with a blocking
anti-IL-10 monoclonal antibody (mAb) partially corrected abnormalities
in CD69 expression and intracellular pH; however, in 1/5 patients stu
died, no significant positive effect was observed. The effect of the a
nti-IL-10 mAb was apparently not related to protection against activat
ion-induced cell death. We conclude that IL-10 in normal PBMNC induce
some of the defects in early cell activation events seen in SLE lympho
cytes. Accordingly, the blockade of IL-10 partially corrects these abn
ormalities in SLE cells. Our data further support the importance of IL
-10 in immune dysfunction seen in SLE. (C) 1998 Academic Press